GB2060380B - Composition for stimulating phagocytic activity comprising muramidase and a hyaluronic acid salt - Google Patents
Composition for stimulating phagocytic activity comprising muramidase and a hyaluronic acid saltInfo
- Publication number
- GB2060380B GB2060380B GB8032722A GB8032722A GB2060380B GB 2060380 B GB2060380 B GB 2060380B GB 8032722 A GB8032722 A GB 8032722A GB 8032722 A GB8032722 A GB 8032722A GB 2060380 B GB2060380 B GB 2060380B
- Authority
- GB
- United Kingdom
- Prior art keywords
- muramidase
- composition
- acid salt
- hyaluronic acid
- phagocytic activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
- 102000016943 Muramidase Human genes 0.000 title 1
- 108010014251 Muramidase Proteins 0.000 title 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 title 1
- 235000010335 lysozyme Nutrition 0.000 title 1
- 229940051921 muramidase Drugs 0.000 title 1
- 230000000242 pagocytic effect Effects 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/084,615 US4272522A (en) | 1979-10-15 | 1979-10-15 | Method for stimulating phagocytic activity and synergistic compositions therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB2060380A GB2060380A (en) | 1981-05-07 |
| GB2060380B true GB2060380B (en) | 1983-08-10 |
Family
ID=22186108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8032722A Expired GB2060380B (en) | 1979-10-15 | 1980-10-10 | Composition for stimulating phagocytic activity comprising muramidase and a hyaluronic acid salt |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4272522A (enExample) |
| JP (1) | JPS5663921A (enExample) |
| CA (1) | CA1151541A (enExample) |
| FR (1) | FR2466990A1 (enExample) |
| GB (1) | GB2060380B (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
| IT1212892B (it) * | 1983-10-11 | 1989-11-30 | Della Valle Francesco | Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica |
| US5166331A (en) * | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
| JPS5995221A (ja) * | 1982-11-20 | 1984-06-01 | Mochida Pharmaceut Co Ltd | 食細胞機能調節作用を有する医薬組成物 |
| US4500676A (en) * | 1983-12-15 | 1985-02-19 | Biomatrix, Inc. | Hyaluronate modified polymeric articles |
| US4487865A (en) * | 1983-12-15 | 1984-12-11 | Biomatrix, Inc. | Polymeric articles modified with hyaluronate |
| JPS6147418A (ja) * | 1984-08-13 | 1986-03-07 | Seikagaku Kogyo Co Ltd | ヒアルロン酸含有胃粘膜保護剤 |
| US4801475A (en) * | 1984-08-23 | 1989-01-31 | Gregory Halpern | Method of hydrophilic coating of plastics |
| US4713448A (en) * | 1985-03-12 | 1987-12-15 | Biomatrix, Inc. | Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues |
| US5099013A (en) * | 1985-03-12 | 1992-03-24 | Biomatrix, Inc, | Hylan preparation and method of recovery thereof from animal tissues |
| US4663233A (en) * | 1985-10-24 | 1987-05-05 | Universal High Technologies | Lens with hydrophilic coating |
| DE3684887D1 (de) * | 1985-11-29 | 1992-05-21 | Biomatrix Inc | Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung. |
| US4808576A (en) * | 1986-04-28 | 1989-02-28 | Mobay Corporation | Remote administration of hyaluronic acid to mammals |
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| US5102783A (en) * | 1990-01-12 | 1992-04-07 | Vetrepharm, Inc. | Composition and method for culturing and freezing cells and tissues |
| CA2061703C (en) * | 1992-02-20 | 2002-07-02 | Rudolf E. Falk | Formulations containing hyaluronic acid |
| US5639738A (en) * | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US5990096A (en) * | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US5824658A (en) * | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US5990095A (en) * | 1991-07-03 | 1999-11-23 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| WO1994007505A1 (en) * | 1991-07-03 | 1994-04-14 | Norpharmco Inc. | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5817644A (en) * | 1991-07-03 | 1998-10-06 | Hyal Pharmaceutical Corporation | Targeting of dosages of medicine and therapeutic agents |
| US5977088A (en) * | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US6022866A (en) * | 1991-07-03 | 2000-02-08 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5792753A (en) * | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
| US6103704A (en) * | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
| US6147059A (en) * | 1992-02-20 | 2000-11-14 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US6218373B1 (en) | 1992-02-20 | 2001-04-17 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US5767106A (en) * | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
| JP4818608B2 (ja) * | 2002-07-03 | 2011-11-16 | ペリコール・サイエンス・インコーポレーテッド | ヒアルロン酸の組成物および使用方法 |
| AU2007295894B2 (en) * | 2006-09-13 | 2013-10-17 | Enhance Skin Products, Inc. | Cosmetic composition for the treatment of skin and methods thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
-
1979
- 1979-10-15 US US06/084,615 patent/US4272522A/en not_active Expired - Lifetime
-
1980
- 1980-10-08 CA CA000361813A patent/CA1151541A/en not_active Expired
- 1980-10-10 GB GB8032722A patent/GB2060380B/en not_active Expired
- 1980-10-13 FR FR8021818A patent/FR2466990A1/fr active Granted
- 1980-10-13 JP JP14214880A patent/JPS5663921A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| CA1151541A (en) | 1983-08-09 |
| FR2466990A1 (fr) | 1981-04-17 |
| JPS636048B2 (enExample) | 1988-02-08 |
| FR2466990B1 (enExample) | 1984-07-27 |
| US4272522A (en) | 1981-06-09 |
| GB2060380A (en) | 1981-05-07 |
| JPS5663921A (en) | 1981-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2060380B (en) | Composition for stimulating phagocytic activity comprising muramidase and a hyaluronic acid salt | |
| GB2093346B (en) | Skin care composition | |
| GB2151924B (en) | Composition for skin care | |
| GB2013493B (en) | Skin treatment products | |
| IL63449A (en) | Antiherpetically active lipstick comprising acid sulphatised polysaccharides | |
| GB8500353D0 (en) | Skin treatment composition | |
| JPS55113760A (en) | Nnsubstituted aziridinee22carboxylic acid derivative and medicine containing it and having immunity stimulating activity | |
| PH24775A (en) | Skin care composition | |
| GB2107589B (en) | Anhydrous composition containing anthralin or a derivative for use in the treatment of skin diseases | |
| HUT38246A (en) | Cosmetic compositions of skin regenerating and hydrating activity and process for producing the active agent | |
| YU220979A (en) | Process for preparing imidazolylvinylether derivatives of a fungicidal and bactericidal activity | |
| HUT37421A (en) | Process for preparing new 4-piperidino-quinazolines and pharmaceutical compositions containing thereof with cardiostimulant activity | |
| GB2184014B (en) | Skin regenerating cosmetic composition | |
| JPS55133377A (en) | 22benzoxepin and pharmacologically acceptable acid addition salt | |
| GB2183156B (en) | Composition for treating skin disease | |
| DE2967214D1 (en) | Product adapted for transcutaneous use | |
| GB2038625B (en) | Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity | |
| GB8527679D0 (en) | Preparing product for human body | |
| PT81534A (en) | Process for preparing benzamides and their salts | |
| GB2126083B (en) | Cosmetic comprising pantetheine-s-sulphonic acid or a salt thereof | |
| DE3278877D1 (en) | Nitroimidazoles having trichomonacidal activity, a process for their preparation and related pharmaceutical compositions | |
| JPS54145225A (en) | Cosmetic with reduced skin stimulation | |
| DE3071737D1 (en) | A salt of 3-thienylmalonic acid and a process for the preparation of 3-thienylmalonic acid | |
| JPS5692872A (en) | 177cyclopropylmethyll144hydroxyy33methoxyy morphinann66one*its acid addition salt and its pharmaceutical use | |
| JPS57156461A (en) | Electric activity imparting body |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
| PE20 | Patent expired after termination of 20 years |
Effective date: 20001009 |